Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

CAH - Cardinal Health, Inc. Latest News | Finranks

Home

CAH

C

Cardinal Health, Inc. (CAH)

NYQ – Real Time Price. Currency in USD

206.58

-1.12 (-0.54%)

At close: Mar 27, 2026, 4:00 PM EDT

204.62

-1.96 (-0.95%)

After-hours: Mar 27, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?

Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?

CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30

DUBLIN, Ohio, March 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?

Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?

CAH sees GLP-1 drugs boost revenue growth, but margins lag as strong demand lifts volumes without significantly improving profitability.

Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B.

CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment

CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment

CAH's $1.8 billion free cash flow fuels buybacks, dividends, and reinvestment, as Cardinal Health eyes disciplined capital deployment and targeted growth opportunities.

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Videos

Cardinal Health CEO says Obamacare subsidies extension under review 'every single day'

Press releases

Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B.

Cardinal Health report highlights cost savings and provider confidence in biosimilars

24.02.2026

Cardinal Health report highlights cost savings and provider confidence in biosimilars

New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains. DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments.

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026.

Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

Revenue increased 19% to $65.6 billion GAAP 1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97 Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63 Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35 Cardinal Health completes annual baseline share repurchase of $750 million Cardinal Health reaches targeted leverage range 3 DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29% to $707 million and GAAP diluted earnings per share (EPS) increased 19% to $1.97.